Welcome to ACCP Learning Management System

Access all your CE needs here!

Upcoming live webinars are listed below

To view the entire CE catalog, click on Catalog in the box to the right

To view CE products that you have already purchased, click on Dashboard in the box to the right. You need to be logged in to view your Dashboard

If you need assistance, email CE@ACCP1.org or phone 571-291-3493 ext 2

Upcoming Live Webinars

  • Includes a Live Web Event on 06/10/2025 at 12:00 PM (EDT)

    This webinar will explore how model-informed drug development (MIDD) techniques are being used to support regulatory approval of new products through the 505(b)(2) pathway. Through detailed case studies, learners will gain practical insight into how the US Food & Drug Administration has accepted model-based justifications for dosing, safety and efficacy, using examples involving fixed-dose combinations, high-potency opioid antagonists and dose optimization in renal or hepatic impairment. Learners that complete this event will understand the significance of model-informed approaches in drug development and regulatory decisions associated with 505(b)(2) submissions.

  • Includes a Live Web Event on 06/25/2025 at 9:15 AM (EDT)

    This webinar will explore how PK bridging is a cornerstone of successful formulation changes, with a specific focus on IV to SC transitions. Industry and regulatory experts will examine how the PK landscape has evolved and share practical, forward-looking strategies—including model-informed drug development approaches—to address the complexities of bridging. Real-world case studies will provide insight into what has worked, what hasn’t, and why. Whether you're in early development or managing a late-stage formulation shift, this session will equip you with the scientific, regulatory and strategic knowledge needed to implement effective PK bridging and streamline development. Attendees will gain a clear understanding of when PK bridging is essential, how to recognize key decision points and what tools and cross-functional perspectives are shaping the future of route transition in drug development. Learners who complete this activity will have enhanced knowledge in the use of PK bridging strategies in therapeutic drug monitoring.

Featured Learning